NCT03713346

Brief Summary

Persons with dairy intolerance may experience cramps/abdominal pain, bloating, flatulence, acute diarrhea, or fecal urgency when they ingest excessive amounts of lactose. The intensity of these conditions can be mild or severe and likely depends on numerous variables including dose, transit time, intestinal residual lactase activity and microbiome potential to ferment lactose. Jersey cattle produce milk containing high levels of the A2 β-casein protein . There are claims that high A2 β-casein milk is more easily digested by people who are lactose maldigesters . We propose to conduct a double-blinded, randomized, controlled trial to determine if high A2 β-casein milk from Jersey cattle is actually better digested and tolerated by lactose maldigesters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 17, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2018

Completed
7 months until next milestone

First Posted

Study publicly available on registry

October 19, 2018

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 3, 2021

Completed
Last Updated

October 8, 2021

Status Verified

October 1, 2021

Enrollment Period

3.6 years

First QC Date

April 4, 2018

Last Update Submit

October 7, 2021

Conditions

Keywords

lactosedairyintolerance

Outcome Measures

Primary Outcomes (1)

  • Differences in AUC ΔH2 concentrations

    Differences in AUC ΔH2 concentrations (primary outcomes) among milk phases is examined by repeated-measures analysis of variance (ANOVA)

    Within the 6 hours following the milk challenge

Secondary Outcomes (1)

  • Differences within each of the symptom categories

    Within the 6 hours following the milk challenge

Study Arms (2)

Lactose digester

OTHER
Other: Lactose free milkOther: Jersey milkOther: High A1 β-casein milkOther: High A2 β-casein milk

Lactose maldigester

OTHER
Other: Lactose free milkOther: Jersey milkOther: High A1 β-casein milkOther: High A2 β-casein milk

Interventions

Single dose of lactose free milk

Lactose digesterLactose maldigester

Single dose of jersey milk

Lactose digesterLactose maldigester

Single dose of high A1 β-casein milk (commercial milk)

Lactose digesterLactose maldigester

Single dose of A2 β-casein milk

Lactose digesterLactose maldigester

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ability/desire to provide informed consent
  • Aged 18 to 65 years of age inclusive at screening
  • Current or recent history of intolerance to and avoidance of milk of at least one month duration (by self-report and self-reported symptoms).
  • Agrees to refrain from all other treatments and products used for lactose intolerance (e.g., Lactaid® Dietary Supplements) during study involvement
  • Willing to return for all study visits and complete all study related procedures, including fasting before and during the hydrogen breath tests
  • Qualifying Lactose Challenge Symptom Score:
  • (4 symptom categories with severity measured on from 0 to 5) as defined by one of the following:
  • At least one score of "moderately severe" or "severe" on a single symptom during the 6 hour HBT test;
  • A score of "moderate" or greater for a single symptom on at least two (2) time points during the 6 hour HBT test;
  • At least one "moderate" score or greater on each of two symptoms during the 6 hour HBT test 7. Hydrogen concentration of at least 20 parts per million greater than baseline at least 2 time points during the screening hydrogren breath test 8. Able to understand and provide written informed consent in English

You may not qualify if:

  • Allergic to milk
  • Currently pregnant
  • Currently lactating
  • Cigarette smoking or other use of tobacco or nicotine containing products within 3 months of screening
  • Diagnosed with any of the following disorders known to be associated with abnormal gastrointestinal motility such as; Gastroparesis, amyloidosis, neuromuscular diseases (including Parkinson's disease), collagen vascular diseases, alcoholism, uremia, malnutrition, or untreated hypothyroidism
  • History of surgery that alters the normal function of the gastrointestinal tract including, but not limited to: gastrointestinal bypass surgery, bariatric surgery, gastric banding, vagotomy, fundoplication, pyloroplasty \[Note: history of uncomplicated abdominal surgeries such as removal of an appendix more than 12 months prior to screening will not be excluded\]
  • Past or present : Organ transplant, chronic pancreatitis, pancreatic insufficiency, symptomatic biliary disease, Celiac disease, chronic constipation, diverticulosis, inflammatory bowel disease (IBD), ulcerative colitis (UC), Crohn's disease (CD), small intestine bacterial overgrowth syndrome (SIBO), gastroparesis, gastro-esophageal reflux disease (GERD), Irritable Bowel Syndrome (IBS) or any other medical condition with symptoms that could confound collection of adverse events.
  • Active ulcers, or history of severe ulcers
  • Diabetes mellitus (type 1 and type 2)
  • Congestive Heart Failure (CHF)
  • Human Immunodeficiency Virus (HIV), Hepatitis B or Hepatitis C
  • BMI \> 35 kg/m2
  • Recent bowel preparation for endoscopic or radiologic investigation within four weeks of screening (e.g., colonoscopy prep)
  • Use of concurrent therapy(ies) or other products (e.g., laxatives, stool softeners, Pepto Bismol®, Lactaid® Dietary Supplements) used for symptoms of lactose intolerance within 7 days of screening
  • Chronic antacid and/or PPI use
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Purdue University

West Lafayette, Indiana, 47907-2059, United States

Location

Related Publications (46)

  • Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC. Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect? Gut. 1997 Nov;41(5):632-5. doi: 10.1136/gut.41.5.632.

    PMID: 9414969BACKGROUND
  • Dairy Farmer. (2011). Specialist A2 milk venture. Cengage Learning, Inc. 2.

    BACKGROUND
  • Brown-Esters, O., Mc Namara, P., & Savaiano, D. (2012). Dietary and biological factors influencing lactose intolerance. International Dairy Journal, 22(2), 98-103.

    BACKGROUND
  • Davies, D.T. & Law, A.J.R. (1980). The content and composition of creamery milks in south-west Scotland. J Dairy Res, 47, 80-90.

    BACKGROUND
  • Carroccio A, Montalto G, Cavera G, Notarbatolo A. Lactose intolerance and self-reported milk intolerance: relationship with lactose maldigestion and nutrient intake. Lactase Deficiency Study Group. J Am Coll Nutr. 1998 Dec;17(6):631-6. doi: 10.1080/07315724.1998.10718813.

    PMID: 9853544BACKGROUND
  • de Silva P, Rachman S. Human food aversions: nature and acquisition. Behav Res Ther. 1987;25(6):457-68. doi: 10.1016/0005-7967(87)90053-2. No abstract available.

    PMID: 3426508BACKGROUND
  • Dehkordi N, Rao DR, Warren AP, Chawan CB. Lactose malabsorption as influenced by chocolate milk, skim milk, sucrose, whole milk, and lactic cultures. J Am Diet Assoc. 1995 Apr;95(4):484-6. doi: 10.1016/S0002-8223(95)00126-3. No abstract available.

    PMID: 7699193BACKGROUND
  • DOELL RG, KRETCHMER N. Studies of small intestine during development. I. Distribution and activity of beta-galactosidase. Biochim Biophys Acta. 1962 Aug 13;62:353-62. doi: 10.1016/0006-3002(62)90097-5. No abstract available.

    PMID: 13886893BACKGROUND
  • Gilliland SE, Kim HS. Effect of viable starter culture bacteria in yogurt on lactose utilization in humans. J Dairy Sci. 1984 Jan;67(1):1-6. doi: 10.3168/jds.S0022-0302(84)81260-6.

    PMID: 6707296BACKGROUND
  • Gustavsson F, Buitenhuis AJ, Johansson M, Bertelsen HP, Glantz M, Poulsen NA, Lindmark Mansson H, Stalhammar H, Larsen LB, Bendixen C, Paulsson M, Andren A. Effects of breed and casein genetic variants on protein profile in milk from Swedish Red, Danish Holstein, and Danish Jersey cows. J Dairy Sci. 2014;97(6):3866-77. doi: 10.3168/jds.2013-7312. Epub 2014 Apr 3.

    PMID: 24704225BACKGROUND
  • Haverberg L, Kwon PH, Scrimshaw NS. Comparative tolerance of adolescents of differing ethic backgrounds to lactose-containing and lactose-free dairy drinks. I. Initial experience with a double-blind procedure. Am J Clin Nutr. 1980 Jan;33(1):17-21. doi: 10.1093/ajcn/33.1.17.

    PMID: 7188826BACKGROUND
  • Hayes, J. (2014). Farm Weekly. A2 milk drinkers may get less gut aches. Global Reference on the Environment, Energy, and Natural Resources.

    BACKGROUND
  • He T, Priebe MG, Harmsen HJ, Stellaard F, Sun X, Welling GW, Vonk RJ. Colonic fermentation may play a role in lactose intolerance in humans. J Nutr. 2006 Jan;136(1):58-63. doi: 10.1093/jn/136.1.58.

    PMID: 16365059BACKGROUND
  • Hertzler SR, Savaiano DA. Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. Am J Clin Nutr. 1996 Aug;64(2):232-6. doi: 10.1093/ajcn/64.2.232.

    PMID: 8694025BACKGROUND
  • Ho S, Woodford K, Kukuljan S, Pal S. Comparative effects of A1 versus A2 beta-casein on gastrointestinal measures: a blinded randomised cross-over pilot study. Eur J Clin Nutr. 2014 Sep;68(9):994-1000. doi: 10.1038/ejcn.2014.127. Epub 2014 Jul 2.

    PMID: 24986816BACKGROUND
  • Johnson AO, Semenya JG, Buchowski MS, Enwonwu CO, Scrimshaw NS. Correlation of lactose maldigestion, lactose intolerance, and milk intolerance. Am J Clin Nutr. 1993 Mar;57(3):399-401. doi: 10.1093/ajcn/57.3.399.

    PMID: 8438774BACKGROUND
  • Johnson AO, Semenya JG, Buchowski MS, Enwonwu CO, Scrimshaw NS. Adaptation of lactose maldigesters to continued milk intakes. Am J Clin Nutr. 1993 Dec;58(6):879-81. doi: 10.1093/ajcn/58.6.879.

    PMID: 8249871BACKGROUND
  • Kolars JC, Levitt MD, Aouji M, Savaiano DA. Yogurt--an autodigesting source of lactose. N Engl J Med. 1984 Jan 5;310(1):1-3. doi: 10.1056/NEJM198401053100101.

    PMID: 6417539BACKGROUND
  • Kretchmer N. On the homology between human development and pediatrics. Pediatr Res. 1968 Jul;2(4):283-6. doi: 10.1203/00006450-196807000-00007. No abstract available.

    PMID: 5669665BACKGROUND
  • Kretchmer N. Lactose and lactase--a historical perspective. Gastroenterology. 1971 Dec;61(6):805-13. No abstract available.

    PMID: 4947662BACKGROUND
  • Lee CM, Hardy CM. Cocoa feeding and human lactose intolerance. Am J Clin Nutr. 1989 May;49(5):840-4. doi: 10.1093/ajcn/49.5.840.

    PMID: 2718917BACKGROUND
  • Leichter J. Comparison of whole milk and skim milk with aqueous lactose solution in lactose tolerance testing. Am J Clin Nutr. 1973 Apr;26(4):393-6. doi: 10.1093/ajcn/26.4.393. No abstract available.

    PMID: 4740264BACKGROUND
  • Lerebours E, N'Djitoyap Ndam C, Lavoine A, Hellot MF, Antoine JM, Colin R. Yogurt and fermented-then-pasteurized milk: effects of short-term and long-term ingestion on lactose absorption and mucosal lactase activity in lactase-deficient subjects. Am J Clin Nutr. 1989 May;49(5):823-7. doi: 10.1093/ajcn/49.5.823.

    PMID: 2497632BACKGROUND
  • Logue AW, Ophir I, Strauss KE. The acquisition of taste aversions in humans. Behav Res Ther. 1981;19(4):319-33. doi: 10.1016/0005-7967(81)90053-x. No abstract available.

    PMID: 7271698BACKGROUND
  • Martini MC, Savaiano DA. Reduced intolerance symptoms from lactose consumed during a meal. Am J Clin Nutr. 1988 Jan;47(1):57-60. doi: 10.1093/ajcn/47.1.57.

    PMID: 3122554BACKGROUND
  • Moore BJ. Dairy Foods: Are They Politically Correct? Nutr Today. 2003 May-Jun;38(3):82-90.

    PMID: 12813186BACKGROUND
  • Newcomer AD, McGill DB, Thomas PJ, Hofmann AF. Tolerance to lactose among lactase-deficient American Indians. Gastroenterology. 1978 Jan;74(1):44-6.

    PMID: 336450BACKGROUND
  • Ng-Kwai-Hang KF & Grosclaude F. (2003). Genetic polymorphism of milk proteins. Advanced Dairy Chemistry, 1, 739-816.

    BACKGROUND
  • Perets, T., Shporn, E., Bareli, Y., Kelner, Y., Levy, S., Aizic, S., Pakanaev, L., Niv, Y., & Dickman, R. (2013). Clinical Accuracy and Usefulness of the Lactose Intolerance Quick Test for the Diagnosis of Lactose Malabsorption. Gastroenterology, 144(5), S473

    BACKGROUND
  • Rask Pedersen E, Jensen BH, Jensen HJ, Keldsbo IL, Hylander Moller E, Norby Rasmussen S. Lactose malabsorption and tolerance of lactose-hydrolyzed milk. A double-blind controlled crossover study. Scand J Gastroenterol. 1982 Oct;17(7):861-4. doi: 10.3109/00365528209181106.

    PMID: 6818684BACKGROUND
  • Reasoner J, Maculan TP, Rand AG, Thayer WR Jr. Clinical studies with low-lactose milk. Am J Clin Nutr. 1981 Jan;34(1):54-60. doi: 10.1093/ajcn/34.1.54.

    PMID: 6893787BACKGROUND
  • Rosensweig NS. Adult human milk intolerance and intestinal lactase deficiency. A review. J Dairy Sci. 1969 May;52(5):585-7. doi: 10.3168/jds.S0022-0302(69)86611-7. No abstract available.

    PMID: 4902392BACKGROUND
  • Savaiano DA, Levitt MD. Milk intolerance and microbe-containing dairy foods. J Dairy Sci. 1987 Feb;70(2):397-406. doi: 10.3168/jds.S0022-0302(87)80023-1.

    PMID: 3553256BACKGROUND
  • Savaiano, D., Hertzler, S., Jackson, A. J., & Suarez, F. L. (2001). Nutrient considerations in lactose intolerance. In A. M. Coulston, C. L. Rock, & E. R. Monsen (Eds.), Nutrition in the prevention and treatment of disease San Diego, CA, USA: Academic Press. 563-575

    BACKGROUND
  • Savaiano DA, AbouElAnouar A, Smith DE, Levitt MD. Lactose malabsorption from yogurt, pasteurized yogurt, sweet acidophilus milk, and cultured milk in lactase-deficient individuals. Am J Clin Nutr. 1984 Dec;40(6):1219-23. doi: 10.1093/ajcn/40.6.1219.

    PMID: 6439026BACKGROUND
  • Scrimshaw NS, Murray E. [Lactose tolerance and milk consumption: myths and realities]. Arch Latinoam Nutr. 1988 Sep;38(3):543-67. Spanish.

    PMID: 3155250BACKGROUND
  • Shermak MA, Saavedra JM, Jackson TL, Huang SS, Bayless TM, Perman JA. Effect of yogurt on symptoms and kinetics of hydrogen production in lactose-malabsorbing children. Am J Clin Nutr. 1995 Nov;62(5):1003-6. doi: 10.1093/ajcn/62.5.1003.

    PMID: 7572723BACKGROUND
  • Simoons FJ. The geographic hypothesis and lactose malabsorption. A weighing of the evidence. Am J Dig Dis. 1978 Nov;23(11):963-80. doi: 10.1007/BF01263095.

    PMID: 362904BACKGROUND
  • Solomons NW, Guerrero AM, Torun B. Dietary manipulation of postprandial colonic lactose fermentation: II. Addition of exogenous, microbial beta-galactosidases at mealtime. Am J Clin Nutr. 1985 Feb;41(2):209-21. doi: 10.1093/ajcn/41.2.209.

    PMID: 3918430BACKGROUND
  • Suarez FL, Adshead J, Furne JK, Levitt MD. Lactose maldigestion is not an impediment to the intake of 1500 mg calcium daily as dairy products. Am J Clin Nutr. 1998 Nov;68(5):1118-22. doi: 10.1093/ajcn/68.5.1118.

    PMID: 9808231BACKGROUND
  • Suarez FL, Savaiano DA, Levitt MD. Review article: the treatment of lactose intolerance. Aliment Pharmacol Ther. 1995 Dec;9(6):589-97. doi: 10.1111/j.1365-2036.1995.tb00427.x.

    PMID: 8824645BACKGROUND
  • Suarez FL, Savaiano D, Arbisi P, Levitt MD. Tolerance to the daily ingestion of two cups of milk by individuals claiming lactose intolerance. Am J Clin Nutr. 1997 May;65(5):1502-6. doi: 10.1093/ajcn/65.5.1502.

    PMID: 9129483BACKGROUND
  • Suchy FJ, Brannon PM, Carpenter TO, Fernandez JR, Gilsanz V, Gould JB, Hall K, Hui SL, Lupton J, Mennella J, Miller NJ, Osganian SK, Sellmeyer DE, Wolf MA. National Institutes of Health Consensus Development Conference: lactose intolerance and health. Ann Intern Med. 2010 Jun 15;152(12):792-6. doi: 10.7326/0003-4819-152-12-201006150-00248. Epub 2010 Apr 19. No abstract available.

    PMID: 20404261BACKGROUND
  • Swagerty DL Jr, Walling AD, Klein RM. Lactose intolerance. Am Fam Physician. 2002 May 1;65(9):1845-50.

    PMID: 12018807BACKGROUND
  • Truswell AS. The A2 milk case: a critical review. Eur J Clin Nutr. 2005 May;59(5):623-31. doi: 10.1038/sj.ejcn.1602104.

    PMID: 15867940BACKGROUND
  • Welsh JD, Hall WH. Gastric emptying of lactose and milk in subjects with lactose malabsorption. Am J Dig Dis. 1977 Dec;22(12):1060-3. doi: 10.1007/BF01072857.

    PMID: 579279BACKGROUND

Study Officials

  • Dennis A Savaiano, PhD

    Purdue University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Virginia Claypool Meredith Professor of Nutrition Policy

Study Record Dates

First Submitted

April 4, 2018

First Posted

October 19, 2018

Study Start

January 17, 2018

Primary Completion

September 3, 2021

Study Completion

September 3, 2021

Last Updated

October 8, 2021

Record last verified: 2021-10

Locations